Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice
出版年份 2022 全文链接
标题
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice
作者
关键词
hepatitis C virus, hepatitis, neutralizing antibodies, HCV vaccine, whole viral particle vaccine, HCV inactivation, HCV downstream processing, adjuvant, envelope glycoprotein, hypervariable region, glycosylation
出版物
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-01-04
DOI
10.1016/j.jhep.2021.12.026
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
- (2021) Kimberly Page et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model
- (2021) Izabela K Ragan et al. Vaccines
- Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity
- (2021) Nicholas A. Brasher et al. Viruses-Basel
- Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
- (2020) Keven Lothert et al. Scientific Reports
- Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
- (2020) Elias H. Augestad et al. Science Advances
- Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells
- (2019) Richard A. Urbanowicz et al. JOURNAL OF VIROLOGY
- Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants
- (2019) Sanne Brun Jensen et al. HEPATOLOGY
- Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations
- (2019) Jannick Prentoe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
- (2019) Zhen-Yong Keck et al. PLoS Pathogens
- Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance
- (2019) Valerie J. Kinchen et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell–Based Vaccine Development
- (2019) Fang Chen et al. GASTROENTEROLOGY
- Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
- (2019) Bassel Akache et al. Vaccines
- Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
- (2018) John L. M. Law et al. JOURNAL OF VIROLOGY
- Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?
- (2018) Valerie J. Kinchen et al. TRENDS IN MICROBIOLOGY
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
- (2018) Ralf Bartenschlager et al. VIRUS RESEARCH
- Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
- (2018) Muriel Lavie et al. Frontiers in Immunology
- Hepatitis C Vaccines, Antibodies, and T Cells
- (2018) Naglaa H. Shoukry Frontiers in Immunology
- Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies
- (2018) Santseharay Ramirez et al. ANTIVIRAL RESEARCH
- Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder
- (2018) Samantha A. Yost et al. Frontiers in Immunology
- Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
- (2018) Jannick Prentoe et al. Frontiers in Immunology
- Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection
- (2018) Valerie J. Kinchen et al. Cell Host & Microbe
- Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants
- (2018) Tanvi Khera et al. JOURNAL OF HEPATOLOGY
- High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals
- (2018) Anne F. Pihl et al. Scientific Reports
- The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs
- (2017) Patricia T. Vietheer et al. HEPATOLOGY
- Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies
- (2016) Catherine Fauvelle et al. Expert Review of Vaccines
- Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model
- (2016) Hiroshi Yokokawa et al. GUT
- Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity
- (2016) Jannick Prentoe et al. HEPATOLOGY
- The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
- (2016) Jens Bukh JOURNAL OF HEPATOLOGY
- Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice
- (2016) Dapeng Li et al. JOURNAL OF VIROLOGY
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant
- (2015) Christian K. Mathiesen et al. JOURNAL OF VIROLOGY
- Immunoglobulin with High-TiterIn VitroCross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge
- (2015) Jens Bukh et al. JOURNAL OF VIROLOGY
- Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
- (2014) William O. Osburn et al. HEPATOLOGY
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1–6
- (2014) Christian K. Mathiesen et al. VIROLOGY
- Neutralizing Antibodies Induced by Cell Culture–Derived Hepatitis C Virus Protect Against Infection in Mice
- (2013) Daisuke Akazawa et al. GASTROENTEROLOGY
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- Identification of Alpha Interferon-Induced Envelope Mutations of Hepatitis C VirusIn VitroAssociated with Increased Viral Fitness and Interferon Resistance
- (2013) Stéphanie B. N. Serre et al. JOURNAL OF VIROLOGY
- Cell-culture-derived HCV—a promising vaccine antigen
- (2013) Judith M. Gottwein et al. Nature Reviews Gastroenterology & Hepatology
- A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
- (2013) John Lok Man Law et al. PLoS One
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
- (2013) R. A. Medina et al. Science Translational Medicine
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
- (2012) E. Giang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses
- (2011) Judith M. Gottwein et al. GASTROENTEROLOGY
- In vivoevaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus
- (2011) Philip Meuleman et al. HEPATOLOGY
- Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
- (2011) Jean-Christophe Meunier et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype
- (2011) A. W. Tarr et al. JOURNAL OF VIROLOGY
- The development of vaccines: how the past led to the future
- (2011) Stanley A. Plotkin et al. NATURE REVIEWS MICROBIOLOGY
- Efficient Culture Adaptation of Hepatitis C Virus Recombinants with Genotype-Specific Core-NS2 by Using Previously Identified Mutations
- (2010) T. K. H. Scheel et al. JOURNAL OF VIROLOGY
- Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
- (2010) J. M. Gottwein et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
- (2010) Sharon E. Frey et al. VACCINE
- Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs
- (2008) Judith M. Gottwein et al. HEPATOLOGY
- Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection
- (2008) Tanja B. Jensen et al. JOURNAL OF INFECTIOUS DISEASES
- Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization
- (2008) T. K. H. Scheel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
- (2007) Catherine A Blish et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now